CBDG (THC Farmaceuticals) Long-Term Debt: $0.93 Mil (As of Jun. 2018)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is THC Farmaceuticals Long-Term Debt?

THC Farmaceuticals CBDG Long-Term Debt is $0.93 Mil as of Jun. 2018.

THC Farmaceuticals's Long-Term Debt for the quarter that ended in Jun. 2018 was $0.93 Mil.

THC Farmaceuticals's quarterly Long-Term Debt increased from Jun. 2017 ($0.00 Mil) to Mar. 2018 ($0.92 Mil) and increased from Mar. 2018 ($0.92 Mil) to Jun. 2018 ($0.93 Mil).

THC Farmaceuticals's annual Long-Term Debt stayed the same from Sep. 2011 ($0.00 Mil) to Sep. 2012 ($0.00 Mil) but then increased from Sep. 2012 ($0.00 Mil) to Sep. 2013 ($0.06 Mil).

THC Farmaceuticals  (OTCPK:CBDG) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

THC Farmaceuticals Long-Term Debt Related Terms

THC Farmaceuticals Long-Term Debt Historical Data

* Premium members only.

The historical data trend for THC Farmaceuticals's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

THC Farmaceuticals Long-Term Debt Chart

THC Farmaceuticals Annual Data
Trend Sep10 Sep11 Sep12 Sep13
Long-Term Debt
0.00 0.00 0.00 0.06

THC Farmaceuticals Quarterly Data
Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Mar17 Jun17 Mar18 Jun18
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.68 0.00 0.00 0.92 0.93
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $0.93 Mil mean?
THC Farmaceuticals (CBDG) has a Long-Term Debt of $0.93 Mil as of Jun. 2018.
Is THC Farmaceuticals' Long-Term Debt too high?
THC Farmaceuticals' current Long-Term Debt is $0.93 Mil.
How does THC Farmaceuticals' Long-Term Debt compare to BOXS?
THC Farmaceuticals' Long-Term Debt of $0.93 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. THC Farmaceuticals's current Long-Term Debt is $0.93 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is THC Farmaceuticals stock overvalued right now?
THC Farmaceuticals (CBDG) has a current Long-Term Debt of $0.93 Mil. The current Long-Term Debt is $0.93 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For THC Farmaceuticals (CBDG), the current Long-Term Debt is $0.93 Mil as of Jun. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

THC Farmaceuticals Business Description

Address 2789 Rio Vista Drive, Suite 3, Saint George, UT, USA, 84790
THC Farmaceuticals Inc is a clinical-stage biotechnology company specializing in the discovery, development, and commercialization of novel cannabinoid-based products in dental, ophthalmology, and other medical disciplines. It offers the combination of proprietary developments with the expertise of clinicians and scientists to unlock the therapeutic properties of cannabis and its bioactive compounds.